{"gene":"CCM2","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":2003,"finding":"CCM2 (MGC4607/malcavernin) was identified as the causative gene for type 2 cerebral cavernous malformations; it encodes a novel protein containing a phosphotyrosine-binding (PTB) domain, similar to the KRIT1 binding partner ICAP1α, suggesting involvement in integrin signaling pathways.","method":"Positional cloning, mutation analysis in CCM2 families, domain analysis","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 — original disease gene identification with 8 distinct mutations in 9 families; independently replicated","pmids":["14624391"],"is_preprint":false},{"year":2004,"finding":"CCM2 gene (MGC4607) was confirmed as the CCM2 locus gene by identification of large genomic deletions and point mutations (loss-of-function) in familial CCM patients; the gene is of unknown function but its inactivation causes cerebral cavernous malformations.","method":"High-density microsatellite genotyping, direct sequencing, deletion mapping","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple independent families, multiple mutation types, replicated","pmids":["14740320"],"is_preprint":false},{"year":2005,"finding":"CCM2 (malcavernin/OSM) directly interacts with CCM1 (KRIT1) via its PTB domain; this interaction is required for proper subcellular localization of CCM1; a familial CCM2 missense mutation abrogates the CCM1/CCM2 interaction; CCM1, CCM2, and MEKK3 form a ternary complex; CCM2 is also involved in p38 MAPK signaling.","method":"Co-immunoprecipitation, fluorescence resonance energy transfer (FRET), subcellular localization studies, missense mutation functional analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Co-IP, FRET, localization), functionally validated with disease mutation","pmids":["16037064"],"is_preprint":false},{"year":2007,"finding":"CCM3 (PDCD10) co-precipitates and co-localizes with CCM2; CCM2 forms a protein complex with STK25 (SOK1/YSK1); CCM3 is phosphorylated by STK25 and dephosphorylated by FAP-1 phosphatase, linking all three CCM proteins in a common signaling pathway.","method":"Co-immunoprecipitation, co-localization, yeast two-hybrid, kinase/phosphatase assays","journal":"Neurogenetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods across CCM protein interactions; replicated complex formation","pmids":["17657516"],"is_preprint":false},{"year":2007,"finding":"Malcavernin (CCM2) binds two of the three NPXY motifs of KRIT1 via its PTB domain; malcavernin protein is cytoplasmic at steady state but can shuttle between nucleus and cytoplasm despite lacking classical nuclear localization or export signals.","method":"Yeast two-hybrid, co-immunoprecipitation, epitope mapping, immunocytochemistry","journal":"Neurosurgery","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding confirmed with multiple methods and epitope mapping","pmids":["17290187"],"is_preprint":false},{"year":2007,"finding":"Mouse preimplantation embryos express CCM2 (the mammalian ortholog of OSM, the osmosensing scaffold for MEKK3) throughout development; CCM2 protein levels increase in response to hyperosmotic media in conjunction with elevated p38 MAPK activation, identifying CCM2 as part of the MEKK3–p38 MAPK osmosensing pathway.","method":"RT-PCR, Western blot, immunofluorescence, hyperosmotic stress assay in embryos","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, expression and biochemical detection without genetic rescue","pmids":["17214902"],"is_preprint":false},{"year":2008,"finding":"An in-frame deletion of CCM2 exon 2 (p.P11_K68del) produces a protein that can interact with CCM3 but loses the ability to interact with CCM1 or to form the CCM1/CCM2/CCM3 ternary complex, demonstrating that the N-terminal region of CCM2 is required for CCM1 binding and that full-length CCM2 is the core of the CCM complex.","method":"Cell culture expression, co-immunoprecipitation, functional mutation analysis","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 2 — domain deletion with functional rescue/failure of complex formation; multiple interaction partners tested","pmids":["18300272"],"is_preprint":false},{"year":2009,"finding":"CCM2 loss in mice results in failed vascular lumen formation and early embryonic death via an endothelial cell-autonomous mechanism; loss of CCM2 activates RHOA GTPase, causing cytoskeletal and cell-junction defects; these phenotypes are rescued by simvastatin (a Rho GTPase inhibitor), establishing CCM2 as a regulator of endothelial cytoskeletal architecture through RHOA.","method":"Endothelial-specific Ccm2 knockout mice, in vitro lumen formation assays, Rho activity assays, pharmacological rescue with simvastatin","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo genetic model plus biochemical Rho activity assays plus pharmacological rescue; replicated by multiple labs","pmids":["19151728"],"is_preprint":false},{"year":2009,"finding":"The physical interaction between KRIT1 (CCM1) and CCM2 is required for localization of both proteins to endothelial cell-cell junctions; loss of either protein sustains RHOA and Rho kinase (ROCK) activity, destabilizing barrier function; Krit1+/− and Ccm2+/− mice exhibit increased vascular leak reversible by the ROCK inhibitor fasudil; human CCM endothelium shows increased myosin light chain phosphorylation consistent with ROCK hyperactivity.","method":"Protein interaction studies, mouse haploinsufficiency models, in vitro permeability assays, ROCK inhibitor treatment, human CCM tissue analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches in mouse and human tissue, pharmacological rescue with ROCK inhibitor","pmids":["20308363"],"is_preprint":false},{"year":2009,"finding":"CCM2 interacts with the E3 ubiquitin ligase Smurf1 via its PTB domain; this interaction promotes Smurf1-mediated ubiquitin-dependent degradation of RhoA; CCM2 does not alter Smurf1 catalytic activity but localizes Smurf1 for RhoA degradation; CCM2 knockdown in brain endothelial cells increases RhoA protein and impairs directed cell migration.","method":"Co-immunoprecipitation, siRNA knockdown, RhoA degradation assay, cell migration assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — novel mechanism with multiple orthogonal methods (IP, ubiquitination assay, migration assay, knockdown)","pmids":["19318350"],"is_preprint":false},{"year":2009,"finding":"CCM2 interacts with the juxtamembrane region of TrkA receptor tyrosine kinase via its PTB domain and mediates TrkA-induced cell death; both the PTB and Karet domains of CCM2 are required for TrkA-dependent death signaling; downregulation of CCM2 in medulloblastoma or neuroblastoma cells attenuates TrkA-dependent death.","method":"Co-immunoprecipitation, domain mutagenesis, siRNA knockdown, cell death assays in tumor cell lines","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — domain mapping, functional knockdown, and multiple cell line validation","pmids":["19755102"],"is_preprint":false},{"year":2009,"finding":"HEG1 receptor is selectively expressed in endothelial cells and couples to KRIT1 at cell junctions; Heg1−/−; Ccm2lacZ/+ mice and Ccm2lacZ/lacZ mice have severe cardiovascular defects, establishing the HEG1-CCM signaling pathway as a crucial regulator of heart and vessel integrity; CCM2 loss in endothelial cells reproduces these junction defects in vitro.","method":"Mouse genetics (knockout, hypomorphic alleles), zebrafish morpholino knockdown, biochemical/imaging analysis of junctions, cell culture","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple in vivo models (mouse, zebrafish) plus cellular validation; pathway placement by genetic epistasis","pmids":["19151727"],"is_preprint":false},{"year":2009,"finding":"Endothelial-specific CCM2 deletion causes embryonic lethality with severe angiogenesis defects in major vessels and heart, while neuroglial-specific deletion causes no cerebrovascular defects, establishing that CCM2 is required cell-autonomously in endothelial cells for proper vascular development.","method":"Tissue-specific conditional Ccm2 knockout mice (Cre-lox), embryonic phenotyping","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 2 — multiple tissue-specific knockouts in vivo with clear cell-type specificity","pmids":["19259391"],"is_preprint":false},{"year":2011,"finding":"Postnatal endothelial-specific Ccm2 deletion (day P1) in mice produces vascular lesions that mimic human CCM, predominantly in the venous bed of cerebellum and retina; CCM lesion formation depends on the developmental timing of Ccm2 ablation, demonstrating that the postnatal angiogenic window is critical for CCM lesion development.","method":"Inducible endothelial-specific Ccm2 conditional knockout mice, histopathology, comparison with Ccm1/Ccm3 deletions","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — clean in vivo genetic model with multiple CCM gene comparisons and timing analysis","pmids":["21859843"],"is_preprint":false},{"year":2011,"finding":"In zebrafish, ccm3 but not ccm2 defects can be rescued by overexpression of stk25b (GCKIII kinase); additional loss of ccm3 in ccm2 mutants synergistically increases cranial vessel dilation, supporting a model where CCM3 acts via GCKIII activity in a pathway distinct from CCM1/CCM2.","method":"Zebrafish genetic epistasis, morpholino knockdown, overexpression rescue experiments","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in vivo with rescue experiments distinguishing CCM2 and CCM3 pathways","pmids":["22182521"],"is_preprint":false},{"year":2012,"finding":"STK25 and STK24 (GCKIII kinases) are novel CCM2 interactors; STK25 (but not STK24) is part of the TrkA/CCM2 death-signaling pathway, can phosphorylate CCM2, and its kinase activity is required for NGF/TrkA-induced death in medulloblastoma cells.","method":"Affinity proteomics (AP-MS), siRNA knockdown, in vitro kinase assay, cell death assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — AP-MS interactome plus kinase assay plus functional rescue/knockdown","pmids":["22782892"],"is_preprint":false},{"year":2012,"finding":"The C-terminus of CCM2 contains a previously uncharacterized folded helical domain structurally homologous to the N-terminal domain of harmonin, named the CCM2 harmonin-homology domain (HHD); the 1.9 Å crystal structure reveals two conformations and an unusually long 13-residue 3(10) helix; analytical ultracentrifugation characterizes its oligomerization state.","method":"X-ray crystallography (1.9 Å resolution), analytical ultracentrifugation","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — crystal structure at high resolution with biophysical validation","pmids":["23266514"],"is_preprint":false},{"year":2013,"finding":"CCM2-like (ccm2l) binds CCM1 (Ccm1) and functions as part of the Heg-CCM pathway in zebrafish cardiovascular development; ccm2 overexpression partially rescues ccm2l morphant defects; deletion and mutational analyses define regions of CCM1 required for binding CCM2, CCM2L, and HEG.","method":"Zebrafish morpholino knockdown, co-injection epistasis, protein binding assays, deletion/mutational mapping","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis plus biochemical domain mapping in two systems","pmids":["23328253"],"is_preprint":false},{"year":2014,"finding":"The CCM2 PTB domain displays preferential binding to the third of three KRIT1 NPX(Y/F) motifs; the 2.75 Å co-crystal structure of the CCM2 PTB domain with KRIT1 NPX(Y/F)3 peptide reveals a Dab-like PTB fold; several disease-associated CCM2 missense mutations destabilize the PTB domain and disrupt KRIT1 binding.","method":"X-ray co-crystallography (2.75 Å), peptide binding assays, missense mutation functional analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — co-crystal structure with functional validation of disease mutations","pmids":["25525273"],"is_preprint":false},{"year":2015,"finding":"Both CCM2 and CCM2L bind MEKK3 in complex with CCM1 and inhibit MEKK3 activation and its phosphorylation of MEK5; knockdown of ccm2l and ccm2 together in zebrafish causes more severe cardiac and body axis defects than ccm2 alone; silencing of mekk3 rescues these defects; CCM2 deletion in endothelial cells activates ERK5 and a transcriptional program downstream of MEKK3.","method":"Co-immunoprecipitation, in vitro kinase assay (MEKK3→MEK5), zebrafish morpholino epistasis, endothelial cell CCM2 deletion","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — kinase assay plus genetic epistasis in zebrafish plus cell biology; independently aligns with Nature 2016 findings","pmids":["26540726"],"is_preprint":false},{"year":2016,"finding":"CCM disease arises from endothelial gain-of-function of MEKK3-KLF2/4 signaling: loss of CCM2 (or CCM1/CCM3) in neonatal mouse endothelium upregulates MEKK3 target genes Klf2 and Klf4, and increases Rho activity; endothelial-specific loss of Mekk3, Klf2, or Klf4 markedly prevents CCM lesion formation; a disease-causing CCM2 mutation abrogates MEKK3 interaction without disrupting CCM complex formation.","method":"Neonatal endothelial-specific knockout mice, transcriptomics of CCM lesion endothelial cells, genetic epistasis, human familial/sporadic CCM tissue analysis, mutant CCM2 biochemistry","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — multiple in vivo models, human tissue validation, biochemical mutation mapping; highly cited foundational study","pmids":["27027284"],"is_preprint":false},{"year":2016,"finding":"Mekk3 heterozygosity prevents CCM lesion formation in Ccm2-deficient neonatal mice, demonstrated by quantitative micro-CT imaging, confirming that MEKK3 is a downstream effector of CCM2 in vivo.","method":"Micro-CT imaging of mouse brains, genetic epistasis (Ccm2 deletion + Mekk3 heterozygosity)","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic epistasis with quantitative imaging endpoint","pmids":["27513872"],"is_preprint":false},{"year":2018,"finding":"The CCM1-CCM2 complex directly orchestrates complementary roles of ROCK1 and ROCK2: CCM proteins act as a scaffold promoting ROCK2 interactions with VE-cadherin and limiting ROCK1 kinase activity; loss of CCM1 or CCM2 leads to excessive ROCK1-dependent actin stress fibers and destabilized junctions; silencing ROCK1 (not ROCK2) restores adhesive/mechanical homeostasis and rescues cardiovascular defects in ccm1 zebrafish.","method":"Co-immunoprecipitation, siRNA knockdown of ROCK isoforms, traction force microscopy, zebrafish rescue experiments","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — multiple methods distinguishing ROCK1 vs ROCK2 roles, validated in vivo in zebrafish","pmids":["30030370"],"is_preprint":false},{"year":2019,"finding":"CCM2 gene has 29 novel exons and 4 novel promoters, generating 50 novel alternatively spliced isoforms and 22 novel protein isoforms with distinct subcellular localization and tissue expression patterns; a novel 'atypical PTB (aPTB) domain' distinct from the canonical PTB domain was discovered; both CCM1 and CCM3 competitively bind this aPTB domain, identifying CCM2 as a dual PTB-domain protein and the cornerstone of the CCM signaling complex.","method":"Genomic/transcriptomic analysis, subcellular fractionation, Co-immunoprecipitation, tissue-specific expression profiling","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 3 — novel structural/domain finding in single lab, multiple methods but complex claims need independent validation","pmids":["31676827"],"is_preprint":false},{"year":2021,"finding":"CCM1- and CCM2-silenced endothelial cells enter a senescence-associated secretory phenotype (SASP) driven by ROCK dysfunction; SASP enables CCM2-deficient cells to invade extracellular matrix and attract surrounding wild-type endothelial and immune cells; ROCK inhibition abrogates this SASP program.","method":"siRNA knockdown, senescence markers (SA-β-gal, p21), transcriptomics, traction force microscopy, ROCK inhibitor treatment, invasion assay","journal":"Angiogenesis","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in single lab; mechanistic novelty (SASP via ROCK) supported by inhibitor experiments","pmids":["34342749"],"is_preprint":false},{"year":2008,"finding":"A two-hit mechanism underlies CCM pathogenesis: biallelic (germline + somatic) mutations in CCM1, CCM2, or CCM3 were identified in affected endothelial cells from CCM lesions; somatic mutations are found only in a subset of lesion endothelial cells, not in interstitial cells, confirming that complete loss of function of a CCM gene in endothelial cells drives lesion formation.","method":"Subcloning and sequencing of bulk amplicons from CCM lesion tissue, immunohistochemistry for CCM protein loss","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — somatic mutation detection in lesion tissue across three CCM genes, consistent with two-hit tumor suppressor model","pmids":["19088123","19088124"],"is_preprint":false}],"current_model":"CCM2 (malcavernin) is a scaffold protein that forms a ternary complex with CCM1 (KRIT1) and CCM3 (PDCD10) via its PTB domain (which binds the third NPXY motif of KRIT1) and its C-terminal harmonin-homology domain; this CCM complex localizes to endothelial cell-cell junctions and suppresses MEKK3 kinase activity and downstream KLF2/4 transcriptional signaling, while also promoting Smurf1-mediated RhoA ubiquitination/degradation and limiting ROCK1 kinase activity, such that loss of CCM2 causes endothelial RHOA/ROCK hyperactivation, cytoskeletal disorganization, barrier dysfunction, and MEKK3-driven transcriptional reprogramming that collectively produce the dilated, hemorrhagic cavernous lesions characteristic of cerebral cavernous malformation disease."},"narrative":{"teleology":[{"year":2003,"claim":"Identification of CCM2 as the causative gene for type 2 cerebral cavernous malformations resolved the molecular basis of the second CCM locus and revealed that the encoded protein harbors a PTB domain suggestive of integrin-associated signaling.","evidence":"Positional cloning and mutation analysis in nine CCM2 families","pmids":["14624391","14740320"],"confidence":"High","gaps":["Binding partners and signaling pathway unknown","Mechanism connecting CCM2 loss to vascular lesion formation uncharacterized"]},{"year":2005,"claim":"Demonstrating that CCM2 directly binds KRIT1 (CCM1) via its PTB domain and that both co-assemble with MEKK3 into a ternary complex established the biochemical core of the CCM signaling pathway and explained why mutations in different CCM genes produce the same disease.","evidence":"Co-immunoprecipitation, FRET, subcellular localization, and disease-mutation functional analysis in cell culture","pmids":["16037064"],"confidence":"High","gaps":["Structural basis of CCM2–KRIT1 interaction unresolved","Downstream signaling consequences of the CCM2–MEKK3 interaction unknown"]},{"year":2007,"claim":"Discovery that CCM3 and GCKIII kinases (STK25) co-precipitate with CCM2 extended the CCM complex to include all three disease gene products and linked them to a common kinase signaling axis.","evidence":"Co-immunoprecipitation, yeast two-hybrid, co-localization, kinase assays","pmids":["17657516","17290187"],"confidence":"High","gaps":["Functional consequence of STK25-mediated phosphorylation on CCM2 unknown","Whether CCM3 acts solely through CCM2 or has independent functions unclear"]},{"year":2008,"claim":"Identification of biallelic (germline + somatic) CCM2 mutations restricted to endothelial cells within lesions established a two-hit tumor-suppressor mechanism for CCM pathogenesis, explaining lesion focality.","evidence":"Subcloning/sequencing of CCM lesion tissue with immunohistochemistry for CCM protein loss","pmids":["19088123","19088124"],"confidence":"High","gaps":["Clonal origin of lesion endothelial cells not fully established","Whether complete CCM2 loss is sufficient or requires additional stochastic events unclear"]},{"year":2009,"claim":"Endothelial-specific Ccm2 knockout mice revealed that CCM2 loss activates RhoA, disrupts vascular lumen formation, and causes embryonic lethality—phenotypes rescued by statin treatment—while the parallel discovery that CCM2 recruits Smurf1 for ubiquitin-dependent RhoA degradation provided the molecular mechanism underlying RhoA hyperactivation.","evidence":"Endothelial-specific conditional knockout mice, Rho activity assays, simvastatin rescue, Smurf1 co-IP, ubiquitination assays, cell migration assays","pmids":["19151728","19318350","19151727","19259391"],"confidence":"High","gaps":["Whether Smurf1-mediated RhoA degradation is the sole mechanism of RhoA regulation by CCM2","Relative contribution of lumen defects versus junction defects to lesion formation unresolved"]},{"year":2009,"claim":"The finding that the CCM1–CCM2 complex localizes to cell–cell junctions and that haploinsufficient mice exhibit ROCK-dependent vascular leak reversible by fasudil established ROCK as a therapeutic target and connected CCM2 to endothelial barrier maintenance.","evidence":"Mouse haploinsufficiency models, permeability assays, ROCK inhibitor treatment, human CCM tissue immunohistochemistry","pmids":["20308363"],"confidence":"High","gaps":["ROCK1 versus ROCK2 isoform specificity not yet distinguished","Long-term efficacy and safety of ROCK inhibition in CCM not tested"]},{"year":2009,"claim":"CCM2 was shown to bind the TrkA receptor via its PTB domain and mediate neurotrophin-induced cell death in neural tumor cells, broadening CCM2 function beyond vascular biology.","evidence":"Co-immunoprecipitation, domain mutagenesis, siRNA knockdown, cell death assays in medulloblastoma/neuroblastoma lines","pmids":["19755102"],"confidence":"High","gaps":["Relevance of TrkA–CCM2 interaction to CCM vascular disease unclear","Downstream death signaling cascade from CCM2/TrkA incompletely mapped"]},{"year":2012,"claim":"High-resolution crystal structures of the CCM2 harmonin-homology domain and, subsequently, the CCM2 PTB–KRIT1 NPX(Y/F)3 co-crystal provided the atomic framework for understanding how disease mutations disrupt complex assembly.","evidence":"X-ray crystallography (1.9 Å HHD; 2.75 Å PTB-peptide complex), analytical ultracentrifugation, peptide binding and mutant analysis","pmids":["23266514","25525273"],"confidence":"High","gaps":["No full-length CCM2 structure available","Structural basis of MEKK3 binding to CCM2 unresolved"]},{"year":2015,"claim":"Demonstrating that CCM2 (and CCM2L) directly inhibit MEKK3 kinase activity toward MEK5, and that mekk3 silencing rescues ccm2 zebrafish defects, placed MEKK3 suppression as a central output of the CCM complex.","evidence":"In vitro kinase assay (MEKK3→MEK5), co-immunoprecipitation, zebrafish morpholino epistasis, endothelial CCM2 deletion transcriptomics","pmids":["26540726"],"confidence":"High","gaps":["Mechanism by which CCM2 inhibits MEKK3 kinase activity not structurally resolved","Relative contribution of ERK5 versus p38 arms downstream of MEKK3 in lesion formation unclear"]},{"year":2016,"claim":"Landmark genetic epistasis in neonatal mice showed that CCM2 loss drives lesion formation through gain-of-function MEKK3–KLF2/KLF4 transcriptional signaling, and that a disease-causing CCM2 mutation selectively disrupts MEKK3 interaction while preserving the CCM1–CCM2–CCM3 complex, separating MEKK3 suppression from complex assembly as distinct CCM2 functions.","evidence":"Neonatal endothelial-specific Ccm2/Mekk3/Klf2/Klf4 knockout mice, lesion endothelial cell transcriptomics, micro-CT quantification, human CCM tissue analysis, CCM2 mutant biochemistry","pmids":["27027284","27513872"],"confidence":"High","gaps":["Molecular basis of how CCM2 suppresses MEKK3 without disrupting complex formation unresolved","Whether KLF2/KLF4 are redundant or each drive distinct pathological features not fully dissected"]},{"year":2018,"claim":"Resolution of ROCK isoform specificity showed that the CCM1–CCM2 complex limits ROCK1 activity while promoting ROCK2–VE-cadherin interactions, establishing that selective ROCK1 hyperactivation drives the cytoskeletal and junctional defects in CCM.","evidence":"ROCK1/ROCK2-selective siRNA, co-immunoprecipitation, traction force microscopy, zebrafish rescue","pmids":["30030370"],"confidence":"High","gaps":["How CCM2 discriminates between ROCK1 and ROCK2 at the molecular level unknown","Whether ROCK1-selective inhibitors have therapeutic advantage over pan-ROCK inhibitors untested in CCM models"]},{"year":null,"claim":"Key open questions include the structural mechanism by which CCM2 inhibits MEKK3, whether CCM2 isoform diversity contributes to tissue-specific disease manifestations, and whether the senescence-associated secretory phenotype induced by CCM2 loss represents a therapeutically targetable step in lesion progression.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No full-length CCM2 structure or CCM2–MEKK3 co-structure exists","Functional significance of >20 predicted CCM2 protein isoforms largely untested","SASP contribution to CCM lesion progression observed only in vitro"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,6,9,19,20,22]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,19,20,22]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,11,22]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,5,7,8,9,19,20]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,1,7,13,20,25]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[10,15]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[8,11,22]}],"complexes":["CCM1-CCM2-CCM3 complex","CCM2-MEKK3 complex"],"partners":["KRIT1","PDCD10","MAP3K3","SMURF1","NTRK1","STK25","STK24","HEG1"],"other_free_text":[]},"mechanistic_narrative":"CCM2 (malcavernin) is an endothelial scaffold protein whose loss-of-function mutations cause cerebral cavernous malformations through a two-hit mechanism [PMID:14624391, PMID:19088123]. Its Dab-like PTB domain binds the third NPXY motif of KRIT1 (CCM1) and recruits the E3 ubiquitin ligase Smurf1 to promote RhoA degradation, while its C-terminal harmonin-homology domain and association with CCM3/GCKIII kinases organize a ternary CCM complex that suppresses MEKK3 kinase activity and downstream KLF2/KLF4 transcriptional signaling [PMID:25525273, PMID:19318350, PMID:27027284]. Loss of CCM2 in endothelial cells causes RHOA/ROCK1 hyperactivation, cytoskeletal disorganization, junction destabilization, and MEKK3-driven transcriptional reprogramming that collectively produce the dilated, hemorrhagic vascular lesions of CCM disease [PMID:19151728, PMID:20308363, PMID:30030370]. Endothelial-specific deletion in neonatal mice recapitulates human CCM lesions, and these are rescued by genetic reduction of Mekk3 or pharmacological ROCK inhibition [PMID:21859843, PMID:27513872]."},"prefetch_data":{"uniprot":{"accession":"Q9BSQ5","full_name":"Cerebral cavernous malformations 2 protein","aliases":["Malcavernin"],"length_aa":444,"mass_kda":48.8,"function":"Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions (By similarity). May function as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a major role in the modulation of MAP3K3-dependent p38 activation induced by hyperosmotic shock (By similarity)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9BSQ5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CCM2","classification":"Not Classified","n_dependent_lines":26,"n_total_lines":1208,"dependency_fraction":0.02152317880794702},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CCM2","total_profiled":1310},"omim":[{"mim_id":"621032","title":"CEREBRAL CAVERNOUS MALFORMATIONS 5; CCM5","url":"https://www.omim.org/entry/621032"},{"mim_id":"619538","title":"CEREBRAL CAVERNOUS MALFORMATIONS 4; CCM4","url":"https://www.omim.org/entry/619538"},{"mim_id":"619402","title":"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 28; CMH28","url":"https://www.omim.org/entry/619402"},{"mim_id":"615466","title":"TALIN ROD DOMAIN-CONTAINING PROTEIN 1; TLNRD1","url":"https://www.omim.org/entry/615466"},{"mim_id":"614182","title":"HEART DEVELOPMENT PROTEIN WITH EGF-LIKE DOMAINS 1; HEG1","url":"https://www.omim.org/entry/614182"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":135.4}],"url":"https://www.proteinatlas.org/search/CCM2"},"hgnc":{"alias_symbol":["MGC4607","OSM"],"prev_symbol":["C7orf22"]},"alphafold":{"accession":"Q9BSQ5","domains":[{"cath_id":"2.30.29.30","chopping":"54-162_191-217","consensus_level":"high","plddt":90.0978,"start":54,"end":217},{"cath_id":"1.20.1160.20","chopping":"292-371","consensus_level":"high","plddt":82.0894,"start":292,"end":371}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BSQ5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BSQ5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BSQ5-F1-predicted_aligned_error_v6.png","plddt_mean":66.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CCM2","jax_strain_url":"https://www.jax.org/strain/search?query=CCM2"},"sequence":{"accession":"Q9BSQ5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BSQ5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BSQ5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BSQ5"}},"corpus_meta":[{"pmid":"8272873","id":"PMC_8272873","title":"Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.","date":"1994","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8272873","citation_count":929,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9334401","id":"PMC_9334401","title":"OSM-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosensation, and olfactory adaptation in Caenorhabditis elegans.","date":"1997","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9334401","citation_count":468,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8999038","id":"PMC_8999038","title":"Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8999038","citation_count":344,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9475731","id":"PMC_9475731","title":"Analysis of osm-6, a gene that affects sensory cilium structure and sensory neuron function in Caenorhabditis elegans.","date":"1998","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9475731","citation_count":203,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16037064","id":"PMC_16037064","title":"CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16037064","citation_count":199,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11290289","id":"PMC_11290289","title":"The C. elegans homolog of the murine cystic kidney disease gene Tg737 functions in a ciliogenic pathway and is disrupted in osm-5 mutant worms.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11290289","citation_count":196,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14740320","id":"PMC_14740320","title":"Mutations within the MGC4607 gene cause cerebral cavernous malformations.","date":"2004","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14740320","citation_count":179,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17000880","id":"PMC_17000880","title":"Mechanism of transport of IFT particles in C. elegans cilia by the concerted action of kinesin-II and OSM-3 motors.","date":"2006","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17000880","citation_count":158,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19088124","id":"PMC_19088124","title":"A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19088124","citation_count":155,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17657516","id":"PMC_17657516","title":"CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.","date":"2007","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/17657516","citation_count":139,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21859843","id":"PMC_21859843","title":"Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice.","date":"2011","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21859843","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7714894","id":"PMC_7714894","title":"Exclusive expression of C. elegans osm-3 kinesin gene in chemosensory neurons open to the external environment.","date":"1995","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7714894","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7690265","id":"PMC_7690265","title":"C. elegans osm-3 gene mediating osmotic avoidance behaviour encodes a kinesin-like protein.","date":"1993","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/7690265","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11676919","id":"PMC_11676919","title":"The bld1 mutation identifies the Chlamydomonas osm-6 homolog as a gene required for flagellar assembly.","date":"2001","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11676919","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29038604","id":"PMC_29038604","title":"Overexpression of OSM and IL-6 impacts the polarization of pro-fibrotic macrophages and the development of bleomycin-induced lung fibrosis.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29038604","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19259391","id":"PMC_19259391","title":"Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations.","date":"2009","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/19259391","citation_count":92,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18700817","id":"PMC_18700817","title":"OSM-11 facilitates LIN-12 Notch signaling during Caenorhabditis elegans vulval development.","date":"2008","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/18700817","citation_count":92,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17000874","id":"PMC_17000874","title":"Autoinhibition regulates the motility of the C. elegans intraflagellar transport motor OSM-3.","date":"2006","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17000874","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34921158","id":"PMC_34921158","title":"Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34921158","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18300272","id":"PMC_18300272","title":"Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.","date":"2008","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18300272","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9920829","id":"PMC_9920829","title":"Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9920829","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8003633","id":"PMC_8003633","title":"Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro.","date":"1994","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/8003633","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17160895","id":"PMC_17160895","title":"Deletions in CCM2 are a common cause of cerebral cavernous malformations.","date":"2006","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17160895","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22182521","id":"PMC_22182521","title":"Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22182521","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26540726","id":"PMC_26540726","title":"The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26540726","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19916861","id":"PMC_19916861","title":"Oncostatin M (OSM) is increased in asthma with incompletely reversible airflow obstruction.","date":"2009","source":"Experimental lung research","url":"https://pubmed.ncbi.nlm.nih.gov/19916861","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37841259","id":"PMC_37841259","title":"The clinical relevance of OSM in inflammatory diseases: a comprehensive review.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37841259","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20809750","id":"PMC_20809750","title":"Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.","date":"2010","source":"Neurosurgical focus","url":"https://pubmed.ncbi.nlm.nih.gov/20809750","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25752217","id":"PMC_25752217","title":"Oncostatin M (OSM) protects against cardiac ischaemia/reperfusion injury in diabetic mice by regulating apoptosis, mitochondrial biogenesis and insulin sensitivity.","date":"2015","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25752217","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8921254","id":"PMC_8921254","title":"Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain.","date":"1996","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8921254","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16648645","id":"PMC_16648645","title":"The molecular identities of the Caenorhabditis elegans intraflagellar transport genes dyf-6, daf-10 and osm-1.","date":"2006","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16648645","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21029238","id":"PMC_21029238","title":"Mutation analysis of CCM1, CCM2 and CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation.","date":"2010","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/21029238","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30936144","id":"PMC_30936144","title":"Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway.","date":"2019","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/30936144","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31007849","id":"PMC_31007849","title":"HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β.","date":"2019","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/31007849","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16465592","id":"PMC_16465592","title":"Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations.","date":"2006","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/16465592","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19755102","id":"PMC_19755102","title":"CCM2 mediates death signaling by the TrkA receptor tyrosine kinase.","date":"2009","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/19755102","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8406444","id":"PMC_8406444","title":"The genes for oncostatin M (OSM) and leukemia inhibitory factor (LIF) are tightly linked on human chromosome 22.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8406444","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29898744","id":"PMC_29898744","title":"OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.","date":"2018","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/29898744","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21253570","id":"PMC_21253570","title":"The Caenorhabditis elegans mucin-like protein OSM-8 negatively regulates osmosensitive physiology via the transmembrane protein PTR-23.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21253570","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18317962","id":"PMC_18317962","title":"OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative).","date":"2008","source":"Cancer investigation","url":"https://pubmed.ncbi.nlm.nih.gov/18317962","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17108126","id":"PMC_17108126","title":"Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17108126","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17214902","id":"PMC_17214902","title":"Mouse preimplantation embryo responses to culture medium osmolarity include increased expression of CCM2 and p38 MAPK activation.","date":"2007","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17214902","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34011405","id":"PMC_34011405","title":"Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.","date":"2021","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/34011405","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7647014","id":"PMC_7647014","title":"The gp 130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells.","date":"1995","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/7647014","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23797667","id":"PMC_23797667","title":"Pulmonary expression of oncostatin M (OSM) promotes inducible BALT formation independently of IL-6, despite a role for IL-6 in OSM-driven pulmonary inflammation.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23797667","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16373645","id":"PMC_16373645","title":"CCM2 expression parallels that of CCM1.","date":"2005","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/16373645","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9505169","id":"PMC_9505169","title":"Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM).","date":"1998","source":"Growth factors (Chur, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/9505169","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30030370","id":"PMC_30030370","title":"The CCM1-CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity.","date":"2018","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/30030370","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8818547","id":"PMC_8818547","title":"Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants.","date":"1996","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/8818547","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28972028","id":"PMC_28972028","title":"MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease.","date":"2017","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/28972028","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25525273","id":"PMC_25525273","title":"Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25525273","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11022130","id":"PMC_11022130","title":"Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.","date":"2000","source":"European cytokine network","url":"https://pubmed.ncbi.nlm.nih.gov/11022130","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34702277","id":"PMC_34702277","title":"Exploring the oncostatin M (OSM) feed-forward signaling of glioblastoma via STAT3 in pan-cancer analysis.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/34702277","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25403688","id":"PMC_25403688","title":"PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.","date":"2014","source":"Neurosurgical review","url":"https://pubmed.ncbi.nlm.nih.gov/25403688","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22262173","id":"PMC_22262173","title":"The Janus face of OSM-mediated cardiomyocyte dedifferentiation during cardiac repair and disease.","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/22262173","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23266514","id":"PMC_23266514","title":"Structural studies of cerebral cavernous malformations 2 (CCM2) reveal a folded helical domain at its C-terminus.","date":"2012","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/23266514","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33122746","id":"PMC_33122746","title":"OSM-9 and OCR-2 TRPV channels are accessorial warm receptors in Caenorhabditis elegans temperature acclimatisation.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33122746","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32736577","id":"PMC_32736577","title":"The role of the oncostatin M/OSM receptor β axis in activating dermal microvascular endothelial cells in systemic sclerosis.","date":"2020","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32736577","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15935618","id":"PMC_15935618","title":"Oncostatin M-induced activation of stress-activated MAP kinases depends on tyrosine 861 in the OSM receptor and requires Jak1 but not Src kinases.","date":"2005","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/15935618","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12543126","id":"PMC_12543126","title":"Molecular cloning and characterisation of a carp (Cyprinus carpio) cytokine-like cDNA that shares sequence similarity with IL-6 subfamily cytokines CNTF, OSM and LIF.","date":"2003","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12543126","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27731314","id":"PMC_27731314","title":"Nicotinamide is an endogenous agonist for a C. elegans TRPV OSM-9 and OCR-4 channel.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27731314","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17440989","id":"PMC_17440989","title":"Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutations.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17440989","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23328253","id":"PMC_23328253","title":"ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23328253","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26093524","id":"PMC_26093524","title":"Notch3/Akt signaling contributes to OSM-induced protection against cardiac ischemia/reperfusion injury.","date":"2015","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/26093524","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21225593","id":"PMC_21225593","title":"Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.","date":"2011","source":"European cells & materials","url":"https://pubmed.ncbi.nlm.nih.gov/21225593","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32195265","id":"PMC_32195265","title":"Molecular Simulation of Oncostatin M and Receptor (OSM-OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease.","date":"2020","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/32195265","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27825852","id":"PMC_27825852","title":"OSM mitigates post-infarction cardiac remodeling and dysfunction by up-regulating autophagy through Mst1 suppression.","date":"2016","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/27825852","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12774951","id":"PMC_12774951","title":"Linkage to the CCM2 locus and genetic heterogeneity in familial cerebral cavernous malformation.","date":"2003","source":"The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","url":"https://pubmed.ncbi.nlm.nih.gov/12774951","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30487773","id":"PMC_30487773","title":"Two Novel KRIT1 and CCM2 Mutations in Patients Affected by Cerebral Cavernous Malformations: New Information on CCM2 Penetrance.","date":"2018","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30487773","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32690652","id":"PMC_32690652","title":"Osteal Tissue Macrophages Are Involved in Endplate Osteosclerosis through the OSM-STAT3/YAP1 Signaling Axis in Modic Changes.","date":"2020","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/32690652","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30373773","id":"PMC_30373773","title":"The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30373773","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8404048","id":"PMC_8404048","title":"Tandem linkage of genes coding for leukemia inhibitory factor (LIF) and oncostatin M (OSM) on human chromosome 22.","date":"1993","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8404048","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29511087","id":"PMC_29511087","title":"The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29511087","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25817464","id":"PMC_25817464","title":"Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.","date":"2015","source":"Journal of reproductive immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25817464","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28626343","id":"PMC_28626343","title":"Anti-OSM Antibody Inhibits Tubulointerstitial Lesion in a Murine Model of Lupus Nephritis.","date":"2017","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/28626343","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37043578","id":"PMC_37043578","title":"CD34+ cell-derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37043578","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31676827","id":"PMC_31676827","title":"Alternatively spliced isoforms reveal a novel type of PTB domain in CCM2 protein.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31676827","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22782892","id":"PMC_22782892","title":"STK25 protein mediates TrkA and CCM2 protein-dependent death in pediatric tumor cells of neural origin.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22782892","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34342749","id":"PMC_34342749","title":"CCM2-deficient endothelial cells undergo a ROCK-dependent reprogramming into senescence-associated secretory phenotype.","date":"2021","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/34342749","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28341548","id":"PMC_28341548","title":"Cos2/Kif7 and Osm-3/Kif17 regulate onset of outer segment development in zebrafish photoreceptors through distinct mechanisms.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28341548","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33845142","id":"PMC_33845142","title":"Cross-reactivity of two human IL-6 family cytokines OSM and LIF explored by protein-protein docking and molecular dynamics simulation.","date":"2021","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/33845142","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36232392","id":"PMC_36232392","title":"OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36232392","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25637691","id":"PMC_25637691","title":"Caenorhabditis elegans OSM-11 signaling regulates SKN-1/Nrf during embryonic development and adult longevity and stress response.","date":"2015","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25637691","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26030441","id":"PMC_26030441","title":"The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26030441","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19799897","id":"PMC_19799897","title":"Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.","date":"2009","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19799897","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26863025","id":"PMC_26863025","title":"A Screen for Modifiers of Cilia Phenotypes Reveals Novel MKS Alleles and Uncovers a Specific Genetic Interaction between osm-3 and nphp-4.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26863025","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19342253","id":"PMC_19342253","title":"Role of a LIF antagonist in LIF and OSM induced MMP-1, MMP-3, and TIMP-1 expression by primary articular chondrocytes.","date":"2009","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/19342253","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17345049","id":"PMC_17345049","title":"Study of cerebral cavernous malformation in Spain and Portugal: high prevalence of a 14 bp deletion in exon 5 of MGC4607 (CCM2 gene).","date":"2007","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17345049","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8833034","id":"PMC_8833034","title":"Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.","date":"1996","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/8833034","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27513872","id":"PMC_27513872","title":"Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27513872","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20419355","id":"PMC_20419355","title":"Genetic variations within KRIT1/CCM1, MGC4607/CCM2 and PDCD10/CCM3 in a large Italian family harbouring a Krit1/CCM1 mutation.","date":"2010","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/20419355","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16133161","id":"PMC_16133161","title":"Organization of phenylalanine ammonia lyase (PAL), acidic PR-5 and osmotin-like (OSM) defence-response gene families in the potato genome.","date":"2005","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/16133161","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25845347","id":"PMC_25845347","title":"OSM is overexpressed in knee osteoarthritis and Notch signaling is involved in the effects of OSM on MC3T3-E1 cell proliferation and differentiation.","date":"2015","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25845347","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19112126","id":"PMC_19112126","title":"Mice overexpressing murine oncostatin M (OSM) exhibit changes in hematopoietic and other organs that are distinct from those of mice overexpressing human OSM or bovine OSM.","date":"2009","source":"Veterinary pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19112126","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21543988","id":"PMC_21543988","title":"A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations.","date":"2011","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21543988","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11055749","id":"PMC_11055749","title":"Temporal expression of mRNAs for neuropoietic cytokines, interleukin-11 (IL-11), oncostatin M (OSM), cardiotrophin-1 (CT-1) and their receptors (IL-11Ralpha and OSMRbeta) in peripheral nerve injury.","date":"2000","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/11055749","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33113505","id":"PMC_33113505","title":"Feiyangchangweiyan capsule protects against ulcerative colitis in mice by modulating the OSM/OSMR pathway and improving gut microbiota.","date":"2020","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33113505","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37120549","id":"PMC_37120549","title":"OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37120549","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8422753","id":"PMC_8422753","title":"Localization of the human oncostatin M gene (OSM) to chromosome 22q12, distal to the Ewing's sarcoma breakpoint.","date":"1993","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8422753","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22378217","id":"PMC_22378217","title":"CCM2 gene polymorphisms in Italian sporadic patients with cerebral cavernous malformation: a case-control study.","date":"2012","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22378217","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25910212","id":"PMC_25910212","title":"Widespread macromolecular interaction perturbations in human genetic disorders.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25910212","citation_count":454,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19151728","id":"PMC_19151728","title":"The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.","date":"2009","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19151728","citation_count":304,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20308363","id":"PMC_20308363","title":"Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.","date":"2010","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20308363","citation_count":277,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14624391","id":"PMC_14624391","title":"Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.","date":"2003","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14624391","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9811928","id":"PMC_9811928","title":"Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9811928","citation_count":256,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27027284","id":"PMC_27027284","title":"Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.","date":"2016","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/27027284","citation_count":255,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19088123","id":"PMC_19088123","title":"Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19088123","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19151727","id":"PMC_19151727","title":"Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway.","date":"2009","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19151727","citation_count":194,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23602568","id":"PMC_23602568","title":"The protein interaction landscape of the human CMGC kinase group.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23602568","citation_count":174,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12690205","id":"PMC_12690205","title":"Human chromosome 7: DNA sequence and biology.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12690205","citation_count":154,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29117863","id":"PMC_29117863","title":"RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.","date":"2017","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29117863","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20379614","id":"PMC_20379614","title":"Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.","date":"2010","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/20379614","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21044950","id":"PMC_21044950","title":"Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells.","date":"2010","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21044950","citation_count":93,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18469344","id":"PMC_18469344","title":"ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18469344","citation_count":90,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15498874","id":"PMC_15498874","title":"Large-scale cDNA transfection screening for genes related to cancer development and progression.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15498874","citation_count":82,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19318350","id":"PMC_19318350","title":"Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19318350","citation_count":73,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20489202","id":"PMC_20489202","title":"Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20489202","citation_count":72,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17290187","id":"PMC_17290187","title":"Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations.","date":"2007","source":"Neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/17290187","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25814554","id":"PMC_25814554","title":"Phospho-tyrosine dependent protein-protein interaction network.","date":"2015","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/25814554","citation_count":61,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51524,"output_tokens":4783,"usd":0.113158},"stage2":{"model":"claude-opus-4-6","input_tokens":8304,"output_tokens":3460,"usd":0.19203},"total_usd":0.649165,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":64363,"output_tokens":6195,"usd":0.143007},"round2_rules_fired":"R2","round2_stage2":{"model":"claude-opus-4-6","input_tokens":10081,"output_tokens":3343,"usd":0.20097}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"CCM2 (malcavernin/OSM scaffold) interacts directly with CCM1 (KRIT1) via its phosphotyrosine binding (PTB) domain; a familial CCM2 missense mutation abrogates this interaction. CCM2 also forms a ternary complex with CCM1 and MEKK3. ICAP1 and CCM2 bind CCM1 via their respective PTB domains and differentially influence CCM1 subcellular localization.\",\n      \"method\": \"Co-immunoprecipitation, FRET, subcellular localization experiments, mutagenesis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, FRET, and localization with functional mutation validation in single study\",\n      \"pmids\": [\"16037064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Loss-of-function mutations (deletions, frameshift, nonsense, splice-site, and initiation codon mutations) in MGC4607 (CCM2) cause familial cerebral cavernous malformations, establishing CCM2 as a causative gene for this vascular disease.\",\n      \"method\": \"Genetic linkage analysis, microsatellite/SNP genotyping, direct sequencing, identification of overlapping deletions in affected families\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal genetic methods, replicated across families\",\n      \"pmids\": [\"14740320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CCM3 (PDCD10) co-precipitates and colocalizes with CCM2, linking these two CCM proteins in a common pathway. Additionally, STK25 forms a protein complex with CCM2, and CCM3 is phosphorylated by STK25.\",\n      \"method\": \"Co-immunoprecipitation, colocalization, yeast two-hybrid, kinase assay\",\n      \"journal\": \"Neurogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP and colocalization, kinase assay, single study\",\n      \"pmids\": [\"17657516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A CCM2 in-frame deletion (exon 2, p.P11_K68del) abolishes CCM2 interaction with CCM1 and prevents formation of the CCM1/CCM2/CCM3 ternary complex, while still permitting CCM2-CCM3 binding. This identifies an N-terminal CCM2 domain required for CCM1 binding and CCM2 as the essential core of the complex.\",\n      \"method\": \"Cell culture expression, co-immunoprecipitation, functional mutation analysis\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with defined deletion mutant, multiple binding partners tested\",\n      \"pmids\": [\"18300272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCM2 interacts with the juxtamembrane region of TrkA receptor tyrosine kinase via its PTB domain and mediates TrkA-induced cell death. Both the PTB domain (for interaction specificity) and the Karet domain (for linking to death pathways) of CCM2 are required for this function. Downregulation of CCM2 attenuates TrkA-dependent death in medulloblastoma/neuroblastoma cells.\",\n      \"method\": \"Co-immunoprecipitation, domain deletion/mutagenesis, siRNA knockdown with cell death assays\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, domain mutagenesis, loss-of-function with defined phenotypic readout\",\n      \"pmids\": [\"19755102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Endothelial-specific deletion of CCM2 severely disrupts angiogenesis, causing morphogenic defects in major blood vessels and heart, leading to embryonic lethality at mid-gestation. Neuroglial-specific CCM2 deletion does not cause cerebrovascular defects, establishing endothelial cells as the primary cell type requiring CCM2 for vascular development.\",\n      \"method\": \"Tissue-specific conditional knockout mouse (Cre/lox), histological analysis\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean tissue-specific KO with defined cellular phenotype and cell-type specificity control\",\n      \"pmids\": [\"19259391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Complete localized loss of CCM2 protein (but not CCM1 or CCM3) is found in cavernous endothelial cells from CCM2 germline mutation carriers, demonstrating endothelial cell mosaicism and that the endothelial cell is the cell of disease origin (two-hit mechanism).\",\n      \"method\": \"Immunohistochemistry on human CCM tissue, genotype-guided protein expression analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — IHC protein-level demonstration of two-hit in endothelial cells, single study\",\n      \"pmids\": [\"19088124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Endothelial-specific Ccm2 deletion at postnatal day 1 in mice produces vascular lesions mimicking human CCM lesions, restricted to the venous bed of cerebellum and retina. The consequences of Ccm2 loss depend on the developmental timing of ablation.\",\n      \"method\": \"Inducible endothelial-specific knockout mouse model (postnatal Cre), histological analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — rigorous conditional KO with developmental timing controls and comparison to CCM1/3 models\",\n      \"pmids\": [\"21859843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In mouse preimplantation embryos, CCM2 expression and upstream p38 MAPK pathway components (MAP3K3/MEKK3, MAP2K3, MAP2K6, MAP2K4) are co-expressed; hyperosmotic culture increases CCM2 levels and p38 MAPK activation, linking CCM2 to osmosensing and p38 MAPK signaling.\",\n      \"method\": \"RT-PCR, Western blot, immunofluorescence, hyperosmotic culture experiments\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — expression and activation data, single study without direct functional knockdown\",\n      \"pmids\": [\"17214902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The CCM2 PTB domain adopts a Dab-like fold and preferentially binds the third NPX(Y/F) motif of KRIT1, as determined by a 2.75 Å co-crystal structure. Disease-associated missense mutations in CCM2 destabilize the PTB domain and disrupt the KRIT1-CCM2 interaction.\",\n      \"method\": \"X-ray crystallography (2.75 Å), co-crystal structure with KRIT1 peptide, mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional mutagenesis validation\",\n      \"pmids\": [\"25525273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The C-terminus of CCM2 contains a folded helical domain (harmonin-homology domain, HHD) that is structurally homologous to the N-terminal domain of harmonin, as revealed by a 1.9 Å crystal structure. CCM2 HHD is observed in two conformations.\",\n      \"method\": \"X-ray crystallography (1.9 Å), analytical ultracentrifugation\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure determination with biophysical validation\",\n      \"pmids\": [\"23266514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Both CCM2 and CCM2L bind MEKK3 in a complex with CCM1 and inhibit MEKK3 activation and its ability to phosphorylate MEK5. CCM2 deletion in endothelial cells leads to activation of ERK5 and a MEKK3-dependent transcriptional program. Silencing of mekk3 rescues CCM-related phenotypes in zebrafish.\",\n      \"method\": \"In vitro binding assays, kinase phosphorylation assay, zebrafish morpholino knockdown with genetic epistasis (mekk3 rescue), endothelial cell CCM2 deletion\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay, epistasis in zebrafish, endothelial KO with signaling readout\",\n      \"pmids\": [\"26540726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The CCM1-CCM2 complex acts as a scaffold that promotes ROCK2 interactions with VE-cadherin and limits ROCK1 kinase activity. Loss of CCM1 or CCM2 produces excessive ROCK1-dependent actin stress fibers and destabilizes intercellular junctions. Silencing ROCK1 (but not ROCK2) restores adhesive and mechanical homeostasis in CCM1/CCM2-depleted endothelial monolayers and rescues cardiovascular defects in ccm1 mutant zebrafish.\",\n      \"method\": \"siRNA knockdown, zebrafish genetic rescue, co-immunoprecipitation, traction force microscopy, monolayer integrity assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, isoform-specific KD with defined mechanical/cellular phenotype, zebrafish in vivo rescue\",\n      \"pmids\": [\"30030370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"STK25 (GCKIII kinase) is identified as a novel CCM2 interactor; STK25 (but not STK24) is required for TrkA/CCM2-mediated death signaling in medulloblastoma cells. CCM2 can be phosphorylated by STK25, and STK25 kinase activity is required for this death pathway.\",\n      \"method\": \"Affinity proteomics/mass spectrometry, co-immunoprecipitation, kinase assay, siRNA knockdown with cell death assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — MS-identified interaction confirmed by Co-IP, kinase assay, KD with phenotype\",\n      \"pmids\": [\"22782892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In zebrafish, ccm2 (valentine) and ccm1 (santa) act in the same pathway for cardiovascular development (Heg-CCM pathway), whereas ccm3 acts through a distinct pathway involving GCKIII kinase stk25b. Additional loss of ccm3 in ccm2 mutants produces a synergistic increase in cranial vessel dilation.\",\n      \"method\": \"Zebrafish genetic mutants/morpholinos, epistasis analysis, rescue experiments with stk25b overexpression\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo with multiple alleles and rescue experiments\",\n      \"pmids\": [\"22182521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ccm2-like (ccm2l) is a component of the Heg-CCM pathway in zebrafish cardiovascular development; Ccm2l binds Ccm1, and ccm2 overexpression can partially rescue ccm2l morphant defects. Deletion analysis defines regions of Ccm1 that mediate binding to Ccm2l versus Ccm2 and Heg.\",\n      \"method\": \"Zebrafish morpholino knockdown, co-injection epistasis, co-immunoprecipitation, deletion/mutational analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with deletion mapping, zebrafish epistasis, single study\",\n      \"pmids\": [\"23328253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CCM2 contains 50 alternatively spliced isoforms encoding 22 novel protein isoforms. CCM2 isoforms exhibit cell- and tissue-specific expression and distinct subcellular compartmentation. An atypical phosphotyrosine binding (aPTB) domain was identified in CCM2, to which both CCM1 and CCM3 can competitively bind, identifying CCM2 as a central scaffold in the CCM signaling complex.\",\n      \"method\": \"Transcriptomic analysis, plasmid transfection and subcellular fractionation, co-immunoprecipitation, domain mapping\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — novel domain identification by Co-IP and fractionation, single study with limited functional validation\",\n      \"pmids\": [\"31676827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Micro-CT imaging in mice showed that heterozygous deletion of Mekk3 prevents CCM lesion formation in Ccm2-deficient postnatal mice, providing in vivo genetic epistasis evidence that MEKK3 acts downstream of CCM2 in CCM pathogenesis.\",\n      \"method\": \"Micro-CT imaging, conditional Ccm2 and Mekk3 knockout mice, genetic epistasis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic epistasis with quantitative imaging readout\",\n      \"pmids\": [\"27513872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCM2-silenced endothelial cells undergo ROCK-dependent reprogramming into a senescence-associated secretory phenotype (SASP), causing extracellular matrix invasion and chemoattraction of surrounding wild-type endothelial and immune cells. This SASP is driven by ROCK dysfunction resulting from CCM2 loss.\",\n      \"method\": \"siRNA knockdown, senescence assays, secretome analysis, transcriptomics, ECM invasion assays\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — KD with defined cellular phenotype (SASP) and mechanistic link to ROCK, single study\",\n      \"pmids\": [\"34342749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Ccm2 is expressed in neurons and choroid plexus but not in vascular endothelium of small cerebral vessels in the mouse brain, with expression patterns similar to Ccm1 and ICAP1, as determined by gene-trap lacZ reporter and in situ hybridization.\",\n      \"method\": \"Gene trap beta-galactosidase reporter, in situ hybridization, heterozygous mouse model showing vascular malformations\",\n      \"journal\": \"Mammalian genome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization by reporter and ISH with functional (heterozygous malformation) context\",\n      \"pmids\": [\"16465592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CCM2 protein is expressed in arterial vascular endothelium, pyramidal neurons, astrocytes and their foot processes in the brain, and in epithelial cells of blood-organ barriers in extracerebral tissues, with a similar spatial and temporal pattern to CCM1 (KRIT1).\",\n      \"method\": \"Western blot, immunohistochemistry with CCM2-specific polyclonal antibodies, in situ hybridization\",\n      \"journal\": \"Stroke\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization by IHC and ISH, supports pathway co-localization with CCM1\",\n      \"pmids\": [\"16373645\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CCM2 (malcavernin) is a scaffold protein that, via its PTB domain (which adopts a Dab-like fold as shown by crystal structure), directly binds KRIT1 (CCM1) at its third NPX(Y/F) motif and assembles a CCM1/CCM2/CCM3 ternary signaling complex; CCM2 also recruits MEKK3 into this complex and suppresses MEKK3-MEK5-ERK5 kinase signaling, while the CCM1–CCM2 scaffold controls ROCK1 and ROCK2 activity to maintain endothelial junctional and cytoskeletal integrity, with loss of endothelial CCM2 causing ROCK1-dependent actin stress fibers, MEKK3 activation, and ultimately the dilated hemorrhagic capillary lesions of cerebral cavernous malformations; CCM2 additionally mediates TrkA receptor-induced cell death in neural tumor cells via STK25 kinase.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"CCM2 (MGC4607/malcavernin) was identified as the causative gene for type 2 cerebral cavernous malformations; it encodes a novel protein containing a phosphotyrosine-binding (PTB) domain, similar to the KRIT1 binding partner ICAP1α, suggesting involvement in integrin signaling pathways.\",\n      \"method\": \"Positional cloning, mutation analysis in CCM2 families, domain analysis\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original disease gene identification with 8 distinct mutations in 9 families; independently replicated\",\n      \"pmids\": [\"14624391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CCM2 gene (MGC4607) was confirmed as the CCM2 locus gene by identification of large genomic deletions and point mutations (loss-of-function) in familial CCM patients; the gene is of unknown function but its inactivation causes cerebral cavernous malformations.\",\n      \"method\": \"High-density microsatellite genotyping, direct sequencing, deletion mapping\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple independent families, multiple mutation types, replicated\",\n      \"pmids\": [\"14740320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CCM2 (malcavernin/OSM) directly interacts with CCM1 (KRIT1) via its PTB domain; this interaction is required for proper subcellular localization of CCM1; a familial CCM2 missense mutation abrogates the CCM1/CCM2 interaction; CCM1, CCM2, and MEKK3 form a ternary complex; CCM2 is also involved in p38 MAPK signaling.\",\n      \"method\": \"Co-immunoprecipitation, fluorescence resonance energy transfer (FRET), subcellular localization studies, missense mutation functional analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Co-IP, FRET, localization), functionally validated with disease mutation\",\n      \"pmids\": [\"16037064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CCM3 (PDCD10) co-precipitates and co-localizes with CCM2; CCM2 forms a protein complex with STK25 (SOK1/YSK1); CCM3 is phosphorylated by STK25 and dephosphorylated by FAP-1 phosphatase, linking all three CCM proteins in a common signaling pathway.\",\n      \"method\": \"Co-immunoprecipitation, co-localization, yeast two-hybrid, kinase/phosphatase assays\",\n      \"journal\": \"Neurogenetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods across CCM protein interactions; replicated complex formation\",\n      \"pmids\": [\"17657516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Malcavernin (CCM2) binds two of the three NPXY motifs of KRIT1 via its PTB domain; malcavernin protein is cytoplasmic at steady state but can shuttle between nucleus and cytoplasm despite lacking classical nuclear localization or export signals.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, epitope mapping, immunocytochemistry\",\n      \"journal\": \"Neurosurgery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding confirmed with multiple methods and epitope mapping\",\n      \"pmids\": [\"17290187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Mouse preimplantation embryos express CCM2 (the mammalian ortholog of OSM, the osmosensing scaffold for MEKK3) throughout development; CCM2 protein levels increase in response to hyperosmotic media in conjunction with elevated p38 MAPK activation, identifying CCM2 as part of the MEKK3–p38 MAPK osmosensing pathway.\",\n      \"method\": \"RT-PCR, Western blot, immunofluorescence, hyperosmotic stress assay in embryos\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, expression and biochemical detection without genetic rescue\",\n      \"pmids\": [\"17214902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"An in-frame deletion of CCM2 exon 2 (p.P11_K68del) produces a protein that can interact with CCM3 but loses the ability to interact with CCM1 or to form the CCM1/CCM2/CCM3 ternary complex, demonstrating that the N-terminal region of CCM2 is required for CCM1 binding and that full-length CCM2 is the core of the CCM complex.\",\n      \"method\": \"Cell culture expression, co-immunoprecipitation, functional mutation analysis\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain deletion with functional rescue/failure of complex formation; multiple interaction partners tested\",\n      \"pmids\": [\"18300272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCM2 loss in mice results in failed vascular lumen formation and early embryonic death via an endothelial cell-autonomous mechanism; loss of CCM2 activates RHOA GTPase, causing cytoskeletal and cell-junction defects; these phenotypes are rescued by simvastatin (a Rho GTPase inhibitor), establishing CCM2 as a regulator of endothelial cytoskeletal architecture through RHOA.\",\n      \"method\": \"Endothelial-specific Ccm2 knockout mice, in vitro lumen formation assays, Rho activity assays, pharmacological rescue with simvastatin\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo genetic model plus biochemical Rho activity assays plus pharmacological rescue; replicated by multiple labs\",\n      \"pmids\": [\"19151728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The physical interaction between KRIT1 (CCM1) and CCM2 is required for localization of both proteins to endothelial cell-cell junctions; loss of either protein sustains RHOA and Rho kinase (ROCK) activity, destabilizing barrier function; Krit1+/− and Ccm2+/− mice exhibit increased vascular leak reversible by the ROCK inhibitor fasudil; human CCM endothelium shows increased myosin light chain phosphorylation consistent with ROCK hyperactivity.\",\n      \"method\": \"Protein interaction studies, mouse haploinsufficiency models, in vitro permeability assays, ROCK inhibitor treatment, human CCM tissue analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches in mouse and human tissue, pharmacological rescue with ROCK inhibitor\",\n      \"pmids\": [\"20308363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCM2 interacts with the E3 ubiquitin ligase Smurf1 via its PTB domain; this interaction promotes Smurf1-mediated ubiquitin-dependent degradation of RhoA; CCM2 does not alter Smurf1 catalytic activity but localizes Smurf1 for RhoA degradation; CCM2 knockdown in brain endothelial cells increases RhoA protein and impairs directed cell migration.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, RhoA degradation assay, cell migration assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — novel mechanism with multiple orthogonal methods (IP, ubiquitination assay, migration assay, knockdown)\",\n      \"pmids\": [\"19318350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCM2 interacts with the juxtamembrane region of TrkA receptor tyrosine kinase via its PTB domain and mediates TrkA-induced cell death; both the PTB and Karet domains of CCM2 are required for TrkA-dependent death signaling; downregulation of CCM2 in medulloblastoma or neuroblastoma cells attenuates TrkA-dependent death.\",\n      \"method\": \"Co-immunoprecipitation, domain mutagenesis, siRNA knockdown, cell death assays in tumor cell lines\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain mapping, functional knockdown, and multiple cell line validation\",\n      \"pmids\": [\"19755102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HEG1 receptor is selectively expressed in endothelial cells and couples to KRIT1 at cell junctions; Heg1−/−; Ccm2lacZ/+ mice and Ccm2lacZ/lacZ mice have severe cardiovascular defects, establishing the HEG1-CCM signaling pathway as a crucial regulator of heart and vessel integrity; CCM2 loss in endothelial cells reproduces these junction defects in vitro.\",\n      \"method\": \"Mouse genetics (knockout, hypomorphic alleles), zebrafish morpholino knockdown, biochemical/imaging analysis of junctions, cell culture\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vivo models (mouse, zebrafish) plus cellular validation; pathway placement by genetic epistasis\",\n      \"pmids\": [\"19151727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Endothelial-specific CCM2 deletion causes embryonic lethality with severe angiogenesis defects in major vessels and heart, while neuroglial-specific deletion causes no cerebrovascular defects, establishing that CCM2 is required cell-autonomously in endothelial cells for proper vascular development.\",\n      \"method\": \"Tissue-specific conditional Ccm2 knockout mice (Cre-lox), embryonic phenotyping\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple tissue-specific knockouts in vivo with clear cell-type specificity\",\n      \"pmids\": [\"19259391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Postnatal endothelial-specific Ccm2 deletion (day P1) in mice produces vascular lesions that mimic human CCM, predominantly in the venous bed of cerebellum and retina; CCM lesion formation depends on the developmental timing of Ccm2 ablation, demonstrating that the postnatal angiogenic window is critical for CCM lesion development.\",\n      \"method\": \"Inducible endothelial-specific Ccm2 conditional knockout mice, histopathology, comparison with Ccm1/Ccm3 deletions\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean in vivo genetic model with multiple CCM gene comparisons and timing analysis\",\n      \"pmids\": [\"21859843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In zebrafish, ccm3 but not ccm2 defects can be rescued by overexpression of stk25b (GCKIII kinase); additional loss of ccm3 in ccm2 mutants synergistically increases cranial vessel dilation, supporting a model where CCM3 acts via GCKIII activity in a pathway distinct from CCM1/CCM2.\",\n      \"method\": \"Zebrafish genetic epistasis, morpholino knockdown, overexpression rescue experiments\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo with rescue experiments distinguishing CCM2 and CCM3 pathways\",\n      \"pmids\": [\"22182521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"STK25 and STK24 (GCKIII kinases) are novel CCM2 interactors; STK25 (but not STK24) is part of the TrkA/CCM2 death-signaling pathway, can phosphorylate CCM2, and its kinase activity is required for NGF/TrkA-induced death in medulloblastoma cells.\",\n      \"method\": \"Affinity proteomics (AP-MS), siRNA knockdown, in vitro kinase assay, cell death assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — AP-MS interactome plus kinase assay plus functional rescue/knockdown\",\n      \"pmids\": [\"22782892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The C-terminus of CCM2 contains a previously uncharacterized folded helical domain structurally homologous to the N-terminal domain of harmonin, named the CCM2 harmonin-homology domain (HHD); the 1.9 Å crystal structure reveals two conformations and an unusually long 13-residue 3(10) helix; analytical ultracentrifugation characterizes its oligomerization state.\",\n      \"method\": \"X-ray crystallography (1.9 Å resolution), analytical ultracentrifugation\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure at high resolution with biophysical validation\",\n      \"pmids\": [\"23266514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CCM2-like (ccm2l) binds CCM1 (Ccm1) and functions as part of the Heg-CCM pathway in zebrafish cardiovascular development; ccm2 overexpression partially rescues ccm2l morphant defects; deletion and mutational analyses define regions of CCM1 required for binding CCM2, CCM2L, and HEG.\",\n      \"method\": \"Zebrafish morpholino knockdown, co-injection epistasis, protein binding assays, deletion/mutational mapping\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis plus biochemical domain mapping in two systems\",\n      \"pmids\": [\"23328253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The CCM2 PTB domain displays preferential binding to the third of three KRIT1 NPX(Y/F) motifs; the 2.75 Å co-crystal structure of the CCM2 PTB domain with KRIT1 NPX(Y/F)3 peptide reveals a Dab-like PTB fold; several disease-associated CCM2 missense mutations destabilize the PTB domain and disrupt KRIT1 binding.\",\n      \"method\": \"X-ray co-crystallography (2.75 Å), peptide binding assays, missense mutation functional analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — co-crystal structure with functional validation of disease mutations\",\n      \"pmids\": [\"25525273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Both CCM2 and CCM2L bind MEKK3 in complex with CCM1 and inhibit MEKK3 activation and its phosphorylation of MEK5; knockdown of ccm2l and ccm2 together in zebrafish causes more severe cardiac and body axis defects than ccm2 alone; silencing of mekk3 rescues these defects; CCM2 deletion in endothelial cells activates ERK5 and a transcriptional program downstream of MEKK3.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay (MEKK3→MEK5), zebrafish morpholino epistasis, endothelial cell CCM2 deletion\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — kinase assay plus genetic epistasis in zebrafish plus cell biology; independently aligns with Nature 2016 findings\",\n      \"pmids\": [\"26540726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CCM disease arises from endothelial gain-of-function of MEKK3-KLF2/4 signaling: loss of CCM2 (or CCM1/CCM3) in neonatal mouse endothelium upregulates MEKK3 target genes Klf2 and Klf4, and increases Rho activity; endothelial-specific loss of Mekk3, Klf2, or Klf4 markedly prevents CCM lesion formation; a disease-causing CCM2 mutation abrogates MEKK3 interaction without disrupting CCM complex formation.\",\n      \"method\": \"Neonatal endothelial-specific knockout mice, transcriptomics of CCM lesion endothelial cells, genetic epistasis, human familial/sporadic CCM tissue analysis, mutant CCM2 biochemistry\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple in vivo models, human tissue validation, biochemical mutation mapping; highly cited foundational study\",\n      \"pmids\": [\"27027284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Mekk3 heterozygosity prevents CCM lesion formation in Ccm2-deficient neonatal mice, demonstrated by quantitative micro-CT imaging, confirming that MEKK3 is a downstream effector of CCM2 in vivo.\",\n      \"method\": \"Micro-CT imaging of mouse brains, genetic epistasis (Ccm2 deletion + Mekk3 heterozygosity)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic epistasis with quantitative imaging endpoint\",\n      \"pmids\": [\"27513872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The CCM1-CCM2 complex directly orchestrates complementary roles of ROCK1 and ROCK2: CCM proteins act as a scaffold promoting ROCK2 interactions with VE-cadherin and limiting ROCK1 kinase activity; loss of CCM1 or CCM2 leads to excessive ROCK1-dependent actin stress fibers and destabilized junctions; silencing ROCK1 (not ROCK2) restores adhesive/mechanical homeostasis and rescues cardiovascular defects in ccm1 zebrafish.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown of ROCK isoforms, traction force microscopy, zebrafish rescue experiments\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods distinguishing ROCK1 vs ROCK2 roles, validated in vivo in zebrafish\",\n      \"pmids\": [\"30030370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CCM2 gene has 29 novel exons and 4 novel promoters, generating 50 novel alternatively spliced isoforms and 22 novel protein isoforms with distinct subcellular localization and tissue expression patterns; a novel 'atypical PTB (aPTB) domain' distinct from the canonical PTB domain was discovered; both CCM1 and CCM3 competitively bind this aPTB domain, identifying CCM2 as a dual PTB-domain protein and the cornerstone of the CCM signaling complex.\",\n      \"method\": \"Genomic/transcriptomic analysis, subcellular fractionation, Co-immunoprecipitation, tissue-specific expression profiling\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — novel structural/domain finding in single lab, multiple methods but complex claims need independent validation\",\n      \"pmids\": [\"31676827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCM1- and CCM2-silenced endothelial cells enter a senescence-associated secretory phenotype (SASP) driven by ROCK dysfunction; SASP enables CCM2-deficient cells to invade extracellular matrix and attract surrounding wild-type endothelial and immune cells; ROCK inhibition abrogates this SASP program.\",\n      \"method\": \"siRNA knockdown, senescence markers (SA-β-gal, p21), transcriptomics, traction force microscopy, ROCK inhibitor treatment, invasion assay\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in single lab; mechanistic novelty (SASP via ROCK) supported by inhibitor experiments\",\n      \"pmids\": [\"34342749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A two-hit mechanism underlies CCM pathogenesis: biallelic (germline + somatic) mutations in CCM1, CCM2, or CCM3 were identified in affected endothelial cells from CCM lesions; somatic mutations are found only in a subset of lesion endothelial cells, not in interstitial cells, confirming that complete loss of function of a CCM gene in endothelial cells drives lesion formation.\",\n      \"method\": \"Subcloning and sequencing of bulk amplicons from CCM lesion tissue, immunohistochemistry for CCM protein loss\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — somatic mutation detection in lesion tissue across three CCM genes, consistent with two-hit tumor suppressor model\",\n      \"pmids\": [\"19088123\", \"19088124\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CCM2 (malcavernin) is a scaffold protein that forms a ternary complex with CCM1 (KRIT1) and CCM3 (PDCD10) via its PTB domain (which binds the third NPXY motif of KRIT1) and its C-terminal harmonin-homology domain; this CCM complex localizes to endothelial cell-cell junctions and suppresses MEKK3 kinase activity and downstream KLF2/4 transcriptional signaling, while also promoting Smurf1-mediated RhoA ubiquitination/degradation and limiting ROCK1 kinase activity, such that loss of CCM2 causes endothelial RHOA/ROCK hyperactivation, cytoskeletal disorganization, barrier dysfunction, and MEKK3-driven transcriptional reprogramming that collectively produce the dilated, hemorrhagic cavernous lesions characteristic of cerebral cavernous malformation disease.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CCM2 (malcavernin) is a scaffold protein central to cerebral cavernous malformation (CCM) signaling, assembling a ternary complex with KRIT1 (CCM1) and CCM3 (PDCD10) to maintain endothelial junctional integrity and regulate kinase signaling during vascular development. Its N-terminal PTB domain adopts a Dab-like fold and binds the third NPX(Y/F) motif of KRIT1, as defined by a 2.75 Å co-crystal structure, while its C-terminal harmonin-homology domain (HHD) provides an additional structural platform [PMID:25525273, PMID:23266514]. CCM2 recruits MEKK3 into the complex and suppresses the MEKK3–MEK5–ERK5 signaling cascade; loss of CCM2 in endothelial cells activates MEKK3-dependent transcription and ROCK1-dependent actin stress fiber formation, destabilizing intercellular junctions, and heterozygous Mekk3 deletion rescues CCM lesions in Ccm2-deficient mice [PMID:26540726, PMID:27513872, PMID:30030370]. Loss-of-function mutations in CCM2 cause familial cerebral cavernous malformations through a two-hit endothelial mechanism, and CCM2 additionally mediates TrkA receptor-induced cell death in neural tumor cells via the GCKIII kinase STK25 [PMID:14740320, PMID:19088124, PMID:19755102, PMID:22782892].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of CCM2 as a disease gene resolved the genetic basis of familial cerebral cavernous malformations mapped to the CCM2 locus, establishing that loss-of-function mutations in this gene are causal.\",\n      \"evidence\": \"Linkage analysis, SNP genotyping, and direct sequencing across multiple affected families\",\n      \"pmids\": [\"14740320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular function of CCM2 protein unknown at this stage\", \"Mechanism linking CCM2 loss to vascular lesion formation unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery that CCM2 directly binds CCM1 via its PTB domain and forms a ternary complex with MEKK3 established CCM2 as a scaffold protein linking the three CCM gene products to kinase signaling, explaining how mutations in different CCM genes converge on one pathway.\",\n      \"evidence\": \"Co-immunoprecipitation, FRET, mutagenesis showing familial missense mutation abrogates CCM1 binding; expression in cultured cells\",\n      \"pmids\": [\"16037064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of PTB-KRIT1 interaction unknown\", \"Downstream signaling consequences of complex disruption not yet tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mapping CCM2 protein expression to arterial endothelium, neurons, and astrocytes demonstrated co-expression with CCM1 and suggested tissue contexts where the CCM2 scaffold functions.\",\n      \"evidence\": \"Immunohistochemistry and in situ hybridization with CCM2-specific antibodies on human and mouse tissues\",\n      \"pmids\": [\"16373645\", \"16465592\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reporter and IHC studies disagreed on small-vessel endothelial expression\", \"Functional significance of neuronal expression not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identification of CCM3 and STK25 as CCM2-binding partners extended the scaffold model to include a GCKIII kinase and a third CCM protein, linking CCM2 to phosphorylation-dependent signaling.\",\n      \"evidence\": \"Co-immunoprecipitation, yeast two-hybrid, in vitro kinase assay\",\n      \"pmids\": [\"17657516\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of STK25–CCM2 interaction on endothelial biology unknown\", \"Specificity among GCKIII kinases not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstration that an N-terminal CCM2 deletion abolishes CCM1 binding but preserves CCM3 binding defined CCM2 as the core scaffold with separable interfaces, and immunohistochemistry on human lesions revealed complete endothelial CCM2 loss consistent with a two-hit mechanism.\",\n      \"evidence\": \"Co-IP with in-frame deletion mutants; IHC on resected human CCM tissue from germline mutation carriers\",\n      \"pmids\": [\"18300272\", \"19088124\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular details of CCM2–CCM3 binding interface unresolved\", \"Two-hit model based on small number of lesions\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Endothelial-specific Ccm2 knockout causing lethal vascular defects—while neuroglial deletion did not—established the endothelium as the critical cell type requiring CCM2, and a parallel study showed CCM2 mediates TrkA-induced death in neural cells via its PTB and Karet domains, revealing a second functional axis.\",\n      \"evidence\": \"Conditional Cre/lox mouse knockouts (endothelial vs. neuroglial); Co-IP, domain mutagenesis, siRNA knockdown with cell death assays in medulloblastoma/neuroblastoma cells\",\n      \"pmids\": [\"19259391\", \"19755102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TrkA–CCM2 axis not tested in endothelial context\", \"Downstream death pathway components beyond CCM2 not fully mapped\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Postnatal endothelial Ccm2 deletion producing venous-bed-restricted lesions mimicking human CCMs provided the first faithful disease model, while zebrafish epistasis showed CCM2 and CCM1 act in the same pathway distinct from CCM3/STK25.\",\n      \"evidence\": \"Inducible endothelial-specific knockout mouse; zebrafish genetic mutants with morpholino epistasis and rescue\",\n      \"pmids\": [\"21859843\", \"22182521\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why lesions are restricted to the venous bed is unexplained\", \"Mechanism of CCM3 partial divergence from CCM1/CCM2 pathway incompletely characterized\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Crystal structure of the CCM2 C-terminal harmonin-homology domain (HHD) at 1.9 Å revealed an unexpected structural fold, and identification of STK25 as the specific GCKIII kinase mediating TrkA/CCM2-dependent death signaling defined the kinase specificity of this axis.\",\n      \"evidence\": \"X-ray crystallography with biophysical validation; affinity proteomics/mass spectrometry, Co-IP, kinase assay, siRNA in medulloblastoma cells\",\n      \"pmids\": [\"23266514\", \"22782892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding partner for the HHD not identified\", \"Whether STK25–CCM2 axis operates in endothelial cells unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"A 2.75 Å co-crystal structure of the CCM2 PTB domain bound to the KRIT1 NPxF peptide provided atomic-resolution detail for the core CCM1–CCM2 interaction and showed that disease-associated missense mutations destabilize this interface.\",\n      \"evidence\": \"X-ray crystallography of CCM2 PTB–KRIT1 peptide complex, mutagenesis validation\",\n      \"pmids\": [\"25525273\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length CCM1–CCM2 complex structure unavailable\", \"Whether PTB domain also recognizes other ligands in vivo not excluded\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstration that CCM2 directly inhibits MEKK3 kinase activity toward MEK5, with CCM2 loss activating ERK5 and a MEKK3-dependent transcriptional program, and MEKK3 silencing rescuing zebrafish CCM phenotypes, established the MEKK3–MEK5–ERK5 cascade as the key downstream effector of CCM2 loss.\",\n      \"evidence\": \"In vitro kinase assay, endothelial CCM2 deletion with signaling readout, zebrafish morpholino rescue\",\n      \"pmids\": [\"26540726\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct structural basis for CCM2-mediated MEKK3 inhibition not determined\", \"Relative contributions of ERK5 vs. other MEKK3 targets to lesion formation unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"In vivo genetic epistasis showing that heterozygous Mekk3 deletion prevents CCM lesion formation in Ccm2-deficient mice provided the strongest mammalian evidence that MEKK3 is the critical downstream target of the CCM2 scaffold in disease pathogenesis.\",\n      \"evidence\": \"Micro-CT imaging in conditional Ccm2/Mekk3 double-knockout mice\",\n      \"pmids\": [\"27513872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Therapeutic window for MEKK3 pathway inhibition in established lesions not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Establishing that the CCM1–CCM2 scaffold differentially regulates ROCK isoforms—promoting ROCK2–VE-cadherin interaction while restraining ROCK1—resolved how CCM2 loss produces actin stress fibers and junction destabilization, with ROCK1 silencing rescuing both cellular and zebrafish phenotypes.\",\n      \"evidence\": \"siRNA isoform-specific knockdown, Co-IP, traction force microscopy, zebrafish genetic rescue\",\n      \"pmids\": [\"30030370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ROCK isoform regulation is direct or through an intermediate is unresolved\", \"Relationship between MEKK3 and ROCK signaling axes downstream of CCM2 not fully integrated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovery that CCM2 loss drives ROCK-dependent senescence-associated secretory phenotype (SASP) in endothelial cells, causing ECM invasion and immune cell recruitment, revealed a non-cell-autonomous mechanism that may contribute to lesion progression.\",\n      \"evidence\": \"siRNA knockdown, senescence assays, secretome analysis, transcriptomics, ECM invasion assays in endothelial cells\",\n      \"pmids\": [\"34342749\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"SASP contribution to lesion growth not validated in vivo\", \"Whether SASP is downstream of MEKK3, ROCK1, or both not determined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for CCM2-mediated inhibition of MEKK3 kinase activity, how the MEKK3–ERK5 and ROCK signaling axes intersect downstream of CCM2, the in vivo significance of the TrkA/STK25 death-signaling axis, and the functional roles of the numerous CCM2 splice isoforms.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of the CCM2–MEKK3 inhibitory complex\", \"Crosstalk between MEKK3–ERK5 and ROCK pathways not mapped\", \"TrkA/STK25 axis not validated in endothelial or in vivo CCM models\", \"Functional significance of 22 CCM2 protein isoforms untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 3, 11, 12, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 16]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 11, 13]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 7, 14]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 6, 17]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 13]}\n    ],\n    \"complexes\": [\n      \"CCM1-CCM2-CCM3 complex\",\n      \"CCM2-MEKK3 complex\"\n    ],\n    \"partners\": [\n      \"KRIT1\",\n      \"PDCD10\",\n      \"MAP3K3\",\n      \"STK25\",\n      \"NTRK1\",\n      \"ROCK1\",\n      \"ROCK2\",\n      \"CCM2L\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"CCM2 (malcavernin) is an endothelial scaffold protein whose loss-of-function mutations cause cerebral cavernous malformations through a two-hit mechanism [PMID:14624391, PMID:19088123]. Its Dab-like PTB domain binds the third NPXY motif of KRIT1 (CCM1) and recruits the E3 ubiquitin ligase Smurf1 to promote RhoA degradation, while its C-terminal harmonin-homology domain and association with CCM3/GCKIII kinases organize a ternary CCM complex that suppresses MEKK3 kinase activity and downstream KLF2/KLF4 transcriptional signaling [PMID:25525273, PMID:19318350, PMID:27027284]. Loss of CCM2 in endothelial cells causes RHOA/ROCK1 hyperactivation, cytoskeletal disorganization, junction destabilization, and MEKK3-driven transcriptional reprogramming that collectively produce the dilated, hemorrhagic vascular lesions of CCM disease [PMID:19151728, PMID:20308363, PMID:30030370]. Endothelial-specific deletion in neonatal mice recapitulates human CCM lesions, and these are rescued by genetic reduction of Mekk3 or pharmacological ROCK inhibition [PMID:21859843, PMID:27513872].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of CCM2 as the causative gene for type 2 cerebral cavernous malformations resolved the molecular basis of the second CCM locus and revealed that the encoded protein harbors a PTB domain suggestive of integrin-associated signaling.\",\n      \"evidence\": \"Positional cloning and mutation analysis in nine CCM2 families\",\n      \"pmids\": [\"14624391\", \"14740320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Binding partners and signaling pathway unknown\",\n        \"Mechanism connecting CCM2 loss to vascular lesion formation uncharacterized\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that CCM2 directly binds KRIT1 (CCM1) via its PTB domain and that both co-assemble with MEKK3 into a ternary complex established the biochemical core of the CCM signaling pathway and explained why mutations in different CCM genes produce the same disease.\",\n      \"evidence\": \"Co-immunoprecipitation, FRET, subcellular localization, and disease-mutation functional analysis in cell culture\",\n      \"pmids\": [\"16037064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of CCM2–KRIT1 interaction unresolved\",\n        \"Downstream signaling consequences of the CCM2–MEKK3 interaction unknown\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that CCM3 and GCKIII kinases (STK25) co-precipitate with CCM2 extended the CCM complex to include all three disease gene products and linked them to a common kinase signaling axis.\",\n      \"evidence\": \"Co-immunoprecipitation, yeast two-hybrid, co-localization, kinase assays\",\n      \"pmids\": [\"17657516\", \"17290187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Functional consequence of STK25-mediated phosphorylation on CCM2 unknown\",\n        \"Whether CCM3 acts solely through CCM2 or has independent functions unclear\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of biallelic (germline + somatic) CCM2 mutations restricted to endothelial cells within lesions established a two-hit tumor-suppressor mechanism for CCM pathogenesis, explaining lesion focality.\",\n      \"evidence\": \"Subcloning/sequencing of CCM lesion tissue with immunohistochemistry for CCM protein loss\",\n      \"pmids\": [\"19088123\", \"19088124\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Clonal origin of lesion endothelial cells not fully established\",\n        \"Whether complete CCM2 loss is sufficient or requires additional stochastic events unclear\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Endothelial-specific Ccm2 knockout mice revealed that CCM2 loss activates RhoA, disrupts vascular lumen formation, and causes embryonic lethality—phenotypes rescued by statin treatment—while the parallel discovery that CCM2 recruits Smurf1 for ubiquitin-dependent RhoA degradation provided the molecular mechanism underlying RhoA hyperactivation.\",\n      \"evidence\": \"Endothelial-specific conditional knockout mice, Rho activity assays, simvastatin rescue, Smurf1 co-IP, ubiquitination assays, cell migration assays\",\n      \"pmids\": [\"19151728\", \"19318350\", \"19151727\", \"19259391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Smurf1-mediated RhoA degradation is the sole mechanism of RhoA regulation by CCM2\",\n        \"Relative contribution of lumen defects versus junction defects to lesion formation unresolved\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The finding that the CCM1–CCM2 complex localizes to cell–cell junctions and that haploinsufficient mice exhibit ROCK-dependent vascular leak reversible by fasudil established ROCK as a therapeutic target and connected CCM2 to endothelial barrier maintenance.\",\n      \"evidence\": \"Mouse haploinsufficiency models, permeability assays, ROCK inhibitor treatment, human CCM tissue immunohistochemistry\",\n      \"pmids\": [\"20308363\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"ROCK1 versus ROCK2 isoform specificity not yet distinguished\",\n        \"Long-term efficacy and safety of ROCK inhibition in CCM not tested\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"CCM2 was shown to bind the TrkA receptor via its PTB domain and mediate neurotrophin-induced cell death in neural tumor cells, broadening CCM2 function beyond vascular biology.\",\n      \"evidence\": \"Co-immunoprecipitation, domain mutagenesis, siRNA knockdown, cell death assays in medulloblastoma/neuroblastoma lines\",\n      \"pmids\": [\"19755102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Relevance of TrkA–CCM2 interaction to CCM vascular disease unclear\",\n        \"Downstream death signaling cascade from CCM2/TrkA incompletely mapped\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"High-resolution crystal structures of the CCM2 harmonin-homology domain and, subsequently, the CCM2 PTB–KRIT1 NPX(Y/F)3 co-crystal provided the atomic framework for understanding how disease mutations disrupt complex assembly.\",\n      \"evidence\": \"X-ray crystallography (1.9 Å HHD; 2.75 Å PTB-peptide complex), analytical ultracentrifugation, peptide binding and mutant analysis\",\n      \"pmids\": [\"23266514\", \"25525273\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No full-length CCM2 structure available\",\n        \"Structural basis of MEKK3 binding to CCM2 unresolved\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that CCM2 (and CCM2L) directly inhibit MEKK3 kinase activity toward MEK5, and that mekk3 silencing rescues ccm2 zebrafish defects, placed MEKK3 suppression as a central output of the CCM complex.\",\n      \"evidence\": \"In vitro kinase assay (MEKK3→MEK5), co-immunoprecipitation, zebrafish morpholino epistasis, endothelial CCM2 deletion transcriptomics\",\n      \"pmids\": [\"26540726\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which CCM2 inhibits MEKK3 kinase activity not structurally resolved\",\n        \"Relative contribution of ERK5 versus p38 arms downstream of MEKK3 in lesion formation unclear\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Landmark genetic epistasis in neonatal mice showed that CCM2 loss drives lesion formation through gain-of-function MEKK3–KLF2/KLF4 transcriptional signaling, and that a disease-causing CCM2 mutation selectively disrupts MEKK3 interaction while preserving the CCM1–CCM2–CCM3 complex, separating MEKK3 suppression from complex assembly as distinct CCM2 functions.\",\n      \"evidence\": \"Neonatal endothelial-specific Ccm2/Mekk3/Klf2/Klf4 knockout mice, lesion endothelial cell transcriptomics, micro-CT quantification, human CCM tissue analysis, CCM2 mutant biochemistry\",\n      \"pmids\": [\"27027284\", \"27513872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular basis of how CCM2 suppresses MEKK3 without disrupting complex formation unresolved\",\n        \"Whether KLF2/KLF4 are redundant or each drive distinct pathological features not fully dissected\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolution of ROCK isoform specificity showed that the CCM1–CCM2 complex limits ROCK1 activity while promoting ROCK2–VE-cadherin interactions, establishing that selective ROCK1 hyperactivation drives the cytoskeletal and junctional defects in CCM.\",\n      \"evidence\": \"ROCK1/ROCK2-selective siRNA, co-immunoprecipitation, traction force microscopy, zebrafish rescue\",\n      \"pmids\": [\"30030370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How CCM2 discriminates between ROCK1 and ROCK2 at the molecular level unknown\",\n        \"Whether ROCK1-selective inhibitors have therapeutic advantage over pan-ROCK inhibitors untested in CCM models\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the structural mechanism by which CCM2 inhibits MEKK3, whether CCM2 isoform diversity contributes to tissue-specific disease manifestations, and whether the senescence-associated secretory phenotype induced by CCM2 loss represents a therapeutically targetable step in lesion progression.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No full-length CCM2 structure or CCM2–MEKK3 co-structure exists\",\n        \"Functional significance of >20 predicted CCM2 protein isoforms largely untested\",\n        \"SASP contribution to CCM lesion progression observed only in vitro\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 6, 9, 19, 20, 22]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 19, 20, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 11, 22]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 5, 7, 8, 9, 19, 20]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 1, 7, 13, 20, 25]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [10, 15]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [8, 11, 22]}\n    ],\n    \"complexes\": [\n      \"CCM1-CCM2-CCM3 complex\",\n      \"CCM2-MEKK3 complex\"\n    ],\n    \"partners\": [\n      \"KRIT1\",\n      \"PDCD10\",\n      \"MAP3K3\",\n      \"SMURF1\",\n      \"NTRK1\",\n      \"STK25\",\n      \"STK24\",\n      \"HEG1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}